Matches in Nanopublications for { ?s ?p "[Since IL-1 appears to be involved in VEGF secretion in glial tumors through an autocrine/paracrine mechanism, recombinant human IL-1-ra may evolve as a new agent for anti-angiogenic glioma therapy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 8 of
8
with 100 items per page.
- NP268252.RAdveuUo0YJyCWIyIuL5QDF0CJl-CVfhEV2eef2DVQA-Y130_assertion description "[Since IL-1 appears to be involved in VEGF secretion in glial tumors through an autocrine/paracrine mechanism, recombinant human IL-1-ra may evolve as a new agent for anti-angiogenic glioma therapy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP268252.RAdveuUo0YJyCWIyIuL5QDF0CJl-CVfhEV2eef2DVQA-Y130_provenance.
- NP490822.RAAWwfbIZcO5YZRucOP4N7O4MQMgxwc9dMa1ndLbu9C90130_assertion description "[Since IL-1 appears to be involved in VEGF secretion in glial tumors through an autocrine/paracrine mechanism, recombinant human IL-1-ra may evolve as a new agent for anti-angiogenic glioma therapy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP490822.RAAWwfbIZcO5YZRucOP4N7O4MQMgxwc9dMa1ndLbu9C90130_provenance.
- NP487565.RAnVVRsjZ5TALPIIUrPiaP97wYEYGvHak4rVELVa2tVko130_assertion description "[Since IL-1 appears to be involved in VEGF secretion in glial tumors through an autocrine/paracrine mechanism, recombinant human IL-1-ra may evolve as a new agent for anti-angiogenic glioma therapy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP487565.RAnVVRsjZ5TALPIIUrPiaP97wYEYGvHak4rVELVa2tVko130_provenance.
- NP489181.RArIonMXtrJc8pupyQrEM-Ly5uqObQeFk9H2XmX1GxyRo130_assertion description "[Since IL-1 appears to be involved in VEGF secretion in glial tumors through an autocrine/paracrine mechanism, recombinant human IL-1-ra may evolve as a new agent for anti-angiogenic glioma therapy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP489181.RArIonMXtrJc8pupyQrEM-Ly5uqObQeFk9H2XmX1GxyRo130_provenance.
- NP268248.RAjfXANmXtlRlK5kpNV9189-G6pY6xAmf_rRyQsON0ATQ130_assertion description "[Since IL-1 appears to be involved in VEGF secretion in glial tumors through an autocrine/paracrine mechanism, recombinant human IL-1-ra may evolve as a new agent for anti-angiogenic glioma therapy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP268248.RAjfXANmXtlRlK5kpNV9189-G6pY6xAmf_rRyQsON0ATQ130_provenance.
- NP268250.RAkVoPhLaCYzxjSa6fFhgY2QptTm82V02CmB3hh11kSGA130_assertion description "[Since IL-1 appears to be involved in VEGF secretion in glial tumors through an autocrine/paracrine mechanism, recombinant human IL-1-ra may evolve as a new agent for anti-angiogenic glioma therapy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP268250.RAkVoPhLaCYzxjSa6fFhgY2QptTm82V02CmB3hh11kSGA130_provenance.
- NP491169.RAPLmYPhrKv6IcWfrCHTqrwIlGRWydmuL75fzobn5yX8s130_assertion description "[Since IL-1 appears to be involved in VEGF secretion in glial tumors through an autocrine/paracrine mechanism, recombinant human IL-1-ra may evolve as a new agent for anti-angiogenic glioma therapy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP491169.RAPLmYPhrKv6IcWfrCHTqrwIlGRWydmuL75fzobn5yX8s130_provenance.
- NP268244.RAHLPGWFhK9MshT66ft1RmnCwHIW-47iyGLu6oF-DewSM130_assertion description "[Since IL-1 appears to be involved in VEGF secretion in glial tumors through an autocrine/paracrine mechanism, recombinant human IL-1-ra may evolve as a new agent for anti-angiogenic glioma therapy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP268244.RAHLPGWFhK9MshT66ft1RmnCwHIW-47iyGLu6oF-DewSM130_provenance.